Pulmonary Circulation

Scope & Guideline

Elevating the discourse in pulmonary and respiratory medicine.

Introduction

Explore the comprehensive scope of Pulmonary Circulation through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Pulmonary Circulation in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2045-8932
PublisherWILEY
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2011 to 2024
AbbreviationPULM CIRC / Pulm. Circ.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Pulmonary Circulation' focuses on advancing the understanding and treatment of pulmonary vascular diseases. Its multi-disciplinary approach encompasses clinical, translational, and basic research, aiming to improve patient outcomes and provide insights into the pathophysiology of pulmonary hypertension and related disorders.
  1. Clinical Research and Trials:
    The journal publishes original research articles that report findings from clinical trials and studies related to pulmonary hypertension, addressing treatment efficacy and patient management strategies.
  2. Pathophysiology and Mechanisms:
    Research exploring the underlying biological mechanisms of pulmonary vascular diseases, including genetic, molecular, and cellular pathways, is a core focus area.
  3. Innovative Therapeutics:
    The journal highlights studies on new and emerging therapies for pulmonary hypertension, including pharmacological treatments, surgical interventions, and novel therapeutic strategies.
  4. Quality of Life and Patient-Centered Outcomes:
    Research addressing the impact of pulmonary vascular diseases on patients' quality of life, including psychosocial aspects and health-related quality of life measures, is emphasized.
  5. Epidemiology and Health Disparities:
    The journal includes studies that investigate the epidemiology of pulmonary hypertension and the disparities in healthcare access and outcomes among different populations.
  6. Multidisciplinary Approaches:
    There is a significant emphasis on collaborative research involving multiple specialties, integrating perspectives from cardiology, pulmonology, hematology, and other relevant fields.
Recent publications in 'Pulmonary Circulation' reveal several emerging themes and trends that reflect the evolving landscape of research in pulmonary vascular diseases.
  1. Long COVID and Its Pulmonary Implications:
    There is an increasing focus on the long-term pulmonary effects of COVID-19, including the development of pulmonary hypertension and related complications in recovered patients.
  2. Integration of Technology in Patient Management:
    Emerging trends include the use of digital health technologies, such as telemedicine and remote monitoring, to manage pulmonary hypertension, reflecting a shift towards patient-centered care.
  3. Precision Medicine and Genetic Research:
    Research exploring genetic markers and personalized treatment approaches is gaining traction, highlighting the importance of tailoring therapies to individual patient profiles.
  4. Environmental and Socioeconomic Factors:
    There is a growing interest in how environmental factors and social determinants of health affect the incidence and outcomes of pulmonary hypertension.
  5. Innovations in Imaging and Biomarkers:
    New techniques in imaging and the identification of novel biomarkers for early detection and monitoring of pulmonary hypertension are being increasingly reported.
  6. Combination Therapy Approaches:
    The exploration of combination therapies, particularly in challenging cases such as chronic thromboembolic pulmonary hypertension and other complex pulmonary conditions, is on the rise.

Declining or Waning

While the journal continues to address a wide range of topics within pulmonary circulation, some traditional areas of focus appear to be declining in prominence based on recent publications.
  1. Historical Case Studies:
    There has been a noticeable decrease in the publication of historical case studies and individual case reports, as the journal moves towards more robust clinical trial data and larger cohort studies.
  2. Basic Science Research:
    Research primarily focused on basic science without direct clinical implications is less frequently featured, as the journal emphasizes translational and clinical relevance.
  3. Single-Center Studies:
    There is a trend away from single-center studies towards multi-center collaborations and larger cohort studies that provide more generalizable results.
  4. Outdated Treatment Protocols:
    Papers discussing older treatment protocols or therapies that are no longer considered standard of care are becoming less common, reflecting a shift towards current best practices and innovations.

Similar Journals

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Advancing respiratory health through cutting-edge research.
Publisher: AMER THORACIC SOCISSN: 1073-449XFrequency: 24 issues/year

American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Connecting Researchers and Practitioners in Clinical Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Therapeutic Advances in Pulmonary and Critical Care Medicine

Elevating standards in critical care research.
Publisher: SAGE PUBLICATIONS LTDISSN: Frequency: 1 issue/year

Therapeutic Advances in Pulmonary and Critical Care Medicine is a leading journal published by SAGE Publications Ltd, dedicated to advancing the fields of pulmonary and critical care medicine. With an emphasis on innovative research, clinical practice, and therapeutic strategies, this journal aims to provide an essential platform for professionals, researchers, and students alike to share groundbreaking findings and insights in a rapidly evolving medical landscape. As an Open Access publication, it ensures that high-quality research is easily accessible to a global audience, facilitating knowledge sharing and collaboration. Though specific metrics such as H-Index and Scopus rankings are currently unlisted, the journal's commitment to rigorous peer review and high academic standards positions it as a vital resource for anyone involved in pulmonary and critical care medicine. With its dedicated editorial board and a diverse array of topics covered, Therapeutic Advances in Pulmonary and Critical Care Medicine stands at the forefront of fostering the latest advancements in the field.

ERJ Open Research

Pioneering Discoveries in Pulmonary Medicine
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: Frequency: 4 issues/year

ERJ Open Research is a distinguished Open Access journal dedicated to advancing the field of pulmonary and respiratory medicine, published by the European Respiratory Society Journals Ltd. Established in 2015, the journal proudly provides a platform for innovative research and comprehensive studies that address vital questions in respiratory health. With an impressive Q1 ranking in Scopus for Pulmonary and Respiratory Medicine and positioned in the top 73rd percentile among its peers, ERJ Open Research is a critical resource for researchers, clinicians, and students alike. The journal’s commitment to open access ensures that high-quality research is readily available to the global community, fostering collaboration and knowledge-sharing. Whether you are looking to publish groundbreaking findings or stay updated on the latest advancements in respiratory medicine, ERJ Open Research is the premier destination for impactful scholarly contributions.

Thoracic Research and Practice

Exploring New Frontiers in Thoracic Research
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

BMC Pulmonary Medicine

Connecting researchers and practitioners for impactful insights.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

RESPIRATION

Bridging Research and Clinical Practice for Better Outcomes
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

HEART & LUNG

Fostering Excellence in Critical Care and Cardiovascular Studies
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

CURRENT OPINION IN PULMONARY MEDICINE

Navigating the Trends in Respiratory Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1070-5287Frequency: 6 issues/year

Current Opinion in Pulmonary Medicine, published by Lippincott Williams & Wilkins, is a vital resource for professionals in the field of pulmonary and respiratory medicine. With a robust ISSN of 1070-5287 and an E-ISSN of 1531-6971, this journal has been converging insightful research and expert opinions since 1995. It currently holds a respectable Q2 category ranking in the 2023 Scopus rankings for pulmonary and respiratory medicine, placing it within the 74th percentile of its field. The journal provides an excellent platform for clinicians, researchers, and students to keep abreast of the latest developments, trends, and therapeutic advances, ensuring that it remains an essential component of ongoing education and scholarship in respiratory health. While not open access, the journal offers various subscription options to facilitate access to cutting-edge pulmonary research. Located in Philadelphia, Pennsylvania, Current Opinion in Pulmonary Medicine continues to shape the future of respiratory medicine through its commitment to high-quality content and academic excellence.

LUNG

Advancing knowledge in pulmonary health since 1959.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.